These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26968629)

  • 21. Methods for detection of subtle mutations in cancer genomes.
    Dahl C; Ralfkiaer U; Guldberg P
    Crit Rev Oncog; 2006 Jul; 12(1-2):41-74. PubMed ID: 17078206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational and epigenetic signatures in cancer tissue linked to environmental exposures and lifestyle.
    Perduca V; Omichessan H; Baglietto L; Severi G
    Curr Opin Oncol; 2018 Jan; 30(1):61-67. PubMed ID: 29076965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer.
    Wojtowicz D; Sason I; Huang X; Kim YA; Leiserson MDM; Przytycka TM; Sharan R
    Genome Med; 2019 Jul; 11(1):49. PubMed ID: 31349863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious.
    Gao F; Chen Y; Levy DN; Conway JA; Kepler TB; Hui H
    J Virol; 2004 Mar; 78(5):2426-33. PubMed ID: 14963138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
    Tan H; Zhou X
    Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.
    de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P
    Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization of tandem repeat mutagenesis in Bacillus subtilis.
    Dormeyer M; Lentes S; Ballin P; Wilkens M; Klumpp S; Kohlheyer D; Stannek L; Grünberger A; Commichau FM
    DNA Repair (Amst); 2018 Mar; 63():10-15. PubMed ID: 29414049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CANCERSIGN: a user-friendly and robust tool for identification and classification of mutational signatures and patterns in cancer genomes.
    Bayati M; Rabiee HR; Mehrbod M; Vafaee F; Ebrahimi D; Forrest ARR; Alinejad-Rokny H
    Sci Rep; 2020 Jan; 10(1):1286. PubMed ID: 31992766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of gene families in human cancer.
    Bardelli A; Velculescu VE
    Curr Opin Genet Dev; 2005 Feb; 15(1):5-12. PubMed ID: 15661527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of DNA repair in tumor suppression.
    Brumer Y; Shakhnovich EI
    Phys Rev E Stat Nonlin Soft Matter Phys; 2004 Dec; 70(6 Pt 1):061912. PubMed ID: 15697407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational processes shape the landscape of TP53 mutations in human cancer.
    Giacomelli AO; Yang X; Lintner RE; McFarland JM; Duby M; Kim J; Howard TP; Takeda DY; Ly SH; Kim E; Gannon HS; Hurhula B; Sharpe T; Goodale A; Fritchman B; Steelman S; Vazquez F; Tsherniak A; Aguirre AJ; Doench JG; Piccioni F; Roberts CWM; Meyerson M; Getz G; Johannessen CM; Root DE; Hahn WC
    Nat Genet; 2018 Oct; 50(10):1381-1387. PubMed ID: 30224644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.
    Wang C; Li J
    Cancer Res; 2020 Nov; 80(21):4644-4654. PubMed ID: 32907840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.
    Jager M; Blokzijl F; Kuijk E; Bertl J; Vougioukalaki M; Janssen R; Besselink N; Boymans S; de Ligt J; Pedersen JS; Hoeijmakers J; Pothof J; van Boxtel R; Cuppen E
    Genome Res; 2019 Jul; 29(7):1067-1077. PubMed ID: 31221724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.